| PRODUCT DESCRIPTION |
| FAMCICLOVIR (DMF) |
| TAMOXIFEN CITRATE BP (PHARMACEUTICAL RAWMATERIALS) |
| LEVOCETIRIZINE DI HCL USP, BATCH NO. 16LC012, MFG. DT. NOV-16 , RETEST. DT. OCT-21. |
| ORGANIC COMPOUNDS 7 CMPD - BENZONITRILEDERIVATIVE - (DTLS AS PER INV) - WE INTEND TO CLAIM REWARDS UNDER MEIS |
| ORGANIC COMPOUNDS 2 CMPD - PYRIMIDINE DERIVATIVE - (DTLS AS PER INV) - WE INTENDTO CLAIM REWARDS UNDER MEIS |
| PHARCEUTICAL RAW MATERIALS CINNARIZINE BP ( UNDER MEIS GROUP C CODE 1130) |
| CETIRIZINE DIHCL EP (CETIRIZINE HCL BP) |
| PHARMACEUTICAL RAW MATERIAL:SILVER SULFADIAZINE USP |
| FLUNARIZINE DI HCL BP/PH.EUR(UNDER MEISSRL NO:1130 GROUP:A) |
| FLUNARIZINE DIHYDROCHLORIDE PH. EUR(UNDER MEIS GROUP-B/SLNO-1130) |
| OTHER COMPOUNDS CNTNG A PYRIMIDINE RING(W/N HYDRGNTD) OR PIPERAZINE RING IN STRUCTURE(KETOCONAZOLE BP) |
| KOPEXIL (DIAMINO PYRIMIDINE OXIDE) |
| LABORATORY CHEMICALS AS PER ATT.INV. # 1314005633 DT. 21.11.2016 |
| ACYCLOVIR |
| FEXOFENADINE HCL |
| ACYCLOVIR |
| VALACYCLOVIR HYDROCHLORIDE |
| QUETIAPINE HEMIFUMARATE IMPURITY B MFG DT. MARCH 2010, RETEST DT. SEPT 2018, BATCH NO. NS/1001/QTF IMP B/48. |
| FREE SAMPLES OF QUETIAPINE FUMARATE USPEFFECTIVE DT. 01.07.2016, USE BEFORE DT.26.06.2017, B NO. W218041601. |
| BUSPIRONE RC-L 8-(4-CHLOROBUTYL)-8-AZASPIRO [4.5] DECANE-7,9-DIONE (APPENDIX 3BMEIS SCHEDULE S/NO:1130) |
| QUETIAPINE FUMARATE |
| TENOFOVIR DISOPROXIL FUMARATE (GROUP-BSRL NO:1130 |
| SUBSTITUTED PYRIMIDINE-CARBOXYLATE (N59178-58-A2) (OTHER 1 R&D COMPOUNDS AS PERINV&PKL) |
| VALACYCLOVIR HYDROCHLORIDE |
| CETIRIZINE DIHYDROCHLORIDE PH. EUR. (MEIS S.NO.1130 & COUNTRY GROUP B) |
| MIRTAZAPINE |
| ACYCLOVIR |
| TRIMETAZIDINE DIHYDROCHLORIDE PH.EUR (GROUP:A,SRL NO:1130 |
| BUTAMIRATE CITRTAE IMPURITY B(QTY:50 MGS(MEIS APPENDIX 3B S.NO:1130) |
| BUTAMIRATE CITRTAE IMPURITY D(QTY:50 MGS(MEIS APPENDIX 3B S.NO:1130) |
| BUTAMIRATE CITRTAE IMPURITY C(QTY:50 MGS(MEIS APPENDIX 3B S.NO:1130) |
| ATORVASTATIN DI-EPOXIDE LACTONE(QTY :25 MG)(MEIS APPENDIX 3B S.NO:1130) |
| BUTAMIRATE CITRTAE IMPURITY A(QTY:50 MGS)(MEIS APPENDIX 3B S.NO:1130) |
| PERINDOPRIL IMP B(QTY:50MG)(QTY :20 MG)(MEIS APPENDIX 3B S.NO:1130) |
| LEVETIRACETAM DEHYDRO ACID(QTY: 100MG)(QTY :15 MG)(MEIS APPENDIX 3B S.NO:1130) |
| CHLOROBENZYLHYDRYL PIPERAZINE (QTY:75 MGS)(MEIS APPENDIX 3B S.NO:1130) |
| VALSARTAN RC E (QTY: 10 MG)(QTY :25 MG)(MEIS APPENDIX 3B S.NO:1130) |
| LEVOCETRIZINE AMIDE(QTY:75 MG)(MEIS APPENDIX 3B S.NO:1130) |
| ACYCLOVIR |
| LEVOCETIRIZINE DIHYDROCHLORIDE IH (GROUP:B,SRL NO:1130 |
| SERTRALINE HYDROCHLORIDE |
| LEVOCETIRIZINE DIHYDROCHLORIDE IH (GROUP:B,SRL NO:1130 |
| VALSARTAN RC D (QTY:10 MG)(MEIS APPENDIX 3B S.NO:1130) |
| VALSARTAN-USP (MFG DT:NOV-2016) (RETESTDATE:OCT-2020) (BATCH NO:VLS/1611205) (MEIS) |
| CHEMICAL - QUINAZOLINE DERIVATIVE - (DTLS AS PER INV) - WE INTEND TO CLAIM REWARDS UNDER MEIS |
| ACYCLOVIR |
| QUETIAPINE FUMARATE MFG DT. OCT 2016, EXP DT. SEP 2021, BATCH NO. H218040017, H218040021. |
| DRUG AND DRUGS INTERMEDIATE POWDER FORM.ALLOPURINOL U.S.P |
| ACYCLOVIR |
| LEVOCETIRIZINE DIHYDROCHLORIDE [GREEN CARD NO:02772 VLDT:04.04.16 VLDT:31.03.2021] |